Protein release from electrospun nonwovens: Improving the release characteristics through rational combination of polyester blend matrices with polidocanol

International Journal of Pharmaceutics

Volumn 477, Issue 1-2, 2014, Pages 273-281

  Puhl, Sebastian ^a   Ilko, David ^a   Li, Linhao ^a,b   Holzgrabe, Ulrike ^a   Meinel, Lorenz ^a   Germershaus, Oliver ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CHONGQING UNIVERSITY   (China)

^c UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

Electrospinning; Lysozyme; Polidocanol; Polycaprolactone; Protein release

Indexed keywords

LYSOZYME; POLIDOCANOL; POLYCAPROLACTONE; POLYGLACTIN; WATER; DRUG CARRIER; LACTIC ACID; MACROGOL DERIVATIVE; POLYESTER; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DESORPTION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTROSPINNING; PARTICLE SIZE; PROCESS DESIGN; PROTEIN SECRETION; SURFACE PROPERTY; SWELLING; WATER ABSORPTION; CHEMISTRY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; SCANNING ELECTRON MICROSCOPY;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MURAMIDASE; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; SURFACE PROPERTIES;

EID: 84908519608     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.10.047     Document Type: Article

References (32)

1. Anderson, J.M., Shive, M.S., 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28, 5-24.
2. Bittiger, H., Marchess, R., Niegisch, W.D., 1970. Crystal structure of poly-eta-caprolactone. Acta Crystallogr. B 26, 1923.
3. Briggs, T., Arinzeh, T.L., 2014. Examining the formulation of emulsion electrospinning for improving the release of bioactive proteins from electrospun fibers. J. Biomed. Mater. Res. A 102, 674-684.
4. Bromberg, L.E., Ron, E.S., 1998. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv. Drug Deliv. Rev. 31, 197-221.
5. Chen, D.R., Bei, J.Z., Wang, S.G., 2000. Polycaprolactone microparticles and their biodegradation. Polym. Degrad. Stabil. 67, 455-459.
6. Cipitria, A., Skelton, A., Dargaville, T.R., Dalton, P.D., Hutmacher, D.W., 2011. Design, fabrication and characterization of PCL electrospun scaffolds-a review. J. Mater. Chem. 21, 9419-9453.
7. Crotts, G., Sah, H., Park, T.G., 1997. Adsorption determines in-vitro protein release rate from biodegradable microspheres: quantitative analysis of surface area during degradation. J. Control Release 47, 101-111.
8. Dash, T.K., Konkimalla, V.B., 2012. Poly-epsilon-caprolactone based formulations for drug delivery and tissue engineering: a review. J. Control Release 158, 15-33.
9. Dordunoo, S.K., Oktaba, A.M.C., Hunter, W., Min, W., Cruz, T., Burt, H.M., 1997. Release of taxol from poly(epsilon-caprolactone) pastes: effect of water-soluble additives. J. Control Release 44, 87-94.
10. Eckmann, D.M., 2009. Polidocanol for endovenous microfoam sclerosant therapy. Exp. Opin. Inv. Drug 18, 1919-1927.
11. Falkner, J.C., Al-Somali, A.M., Jamison, J.A., Zhang, J.Y., Adrianse, S.L., Simpson, R.L., Calabretta, M.K., Radding, W., Phillips, G.N., Colvin, V.L., 2005. Generation of size-controlled, submicrometer protein crystals. Chem. Mater. 17, 2679-2686.
12. Friess, W.F., Schlapp, M., 2002. Release mechanisms from gentamicin loaded poly (lactic-co-glycolic acid) (PLGA) microparticles. J. Pharm. Sci. 91, 845-855.
13. Gorin, G., Wang, S.F., Papapavl, L., 1971. Assay of lysozyme by its lytic action on m-lysodeikticus cells. Anal. Biochem. 39, 113.
14. Gunatillake, P.A., Adhikari, R., 2003. Biodegradable synthetic polymers for tissue engineering. Eur. Cells Mater. 5, 1-16 discussion 16.
15. Higuchi, T., 1963. Mechanism of sustained-action medication - theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52, 1145.
16. Ilko, D., Braun, A., Germershaus, O., Meinel, L., Holzgrabe, U., 2014. Fatty acid composition analysis in polysorbate 80 with high performance liquid chromatography coupled to charged aerosol detection. Eur. J. Pharm. Biopharm submitted.
17. Jiang, H.L., Hu, Y.Q., Li, Y., Zhao, P.C., Zhu, K.J., Chen, W.L., 2005. A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. J. Control Release 108, 237-243.
18. Karami, Z., Rezaeian, I., Zahedi, P., Abdollahi, M., 2013. Preparation and performance evaluations of electrospun poly(epsilon-caprolactone), poly(lactic acid), and their hybrid (50/50) nanofibrous mats containing thymol as an herbal drug for effective wound healing. J. Appl. Polym. Sci. 129, 756-766.
19. Li, Y., Jiang, H.L., Zhu, K.J., 2008. Encapsulation and controlled release of lysozyme from electrospun poly(epsilon-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme-oleate complexes. J. Mater. Sci. 19, 827-832.
20. Liao, Y.H., Brown, M.B., Martin, G.P., 2001. Turbidimetric and HPLC assays for the determination of formulated lysozyme activity. J. Pharm. Pharmacol. 53, 549-554.
21. Liu, Y.J., Jiang, H.L., Li, Y., Zhu, K.J., 2008. Control of dimensional stability and degradation rate in electrospun composite scaffolds composed of poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone). Chin. J. Polym. Sci. 26, 63-71.
22. Lu, C.H., Lin, W.J., 2002. Permeation of protein from porous poly(epsilon-caprolactone) films. J. Biomed. Mater. Res. 63, 220-225.
23. Meinel, A.J., Germershaus, O., Luhmann, T., Merkle, H.P., Meinel, L., 2012. Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur. J. Pharm. Biopharm. 81, 1-13.
24. Pham, Q.P., Sharma, U., Mikos, A.G., 2006. Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules 7, 2796-2805.
25. Puhl, S., Li, L., Meinel, L., Germershaus, O., 2014. Controlled protein delivery from electrospun non-wovens: novel combination of protein crystals and a biodegradable release matrix. Mol. Pharm. 11, 2372-2380.
26. Qin, X.H., Wu, D.Q., 2012. Effect of different solvents on poly(caprolactone) (PCL) electrospun nonwoven membranes. J. Therm. Anal. Calorim. 107, 1007-1013.
27. Sahoo, S., Sasmal, A., Nanda, R., Phani, A.R., Nayak, P.L., 2010. Synthesis of chitosanpolycaprolactone blend for control delivery of ofloxacin drug. Carbohydr. Polym. 79, 106-113.
28. Srikar, R., Yarin, A.L., Megaridis, C.M., Bazilevsky, A.V., Kelley, E., 2008. Desorption-limited mechanism of release from polymer nanofibers. Langmuir 24, 965-974.
29. Wang, X.D., Wang, Y.J., Wei, K., Zhao, N.R., Zhang, S.H., Chen, J.D., 2009. Drug distribution within poly(epsilon-caprolactone) microspheres and in vitro release. J. Mater. Process. Tech. 209, 348-354.
30. Washburn, E.W., 1921. The dynamics of capillary flow. Phys. Rev. 17, 273-283.
31. Wendorff, J.H., Agarwal, S., Greiner, A., 2012. Electrospinning: Materials, Processing, and Applications. Wiley-VCH, Weinheim, Germany.
32. Yang, Y.Y., Chung, T.S., Ng, N.P., 2001. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 22, 231-241.